Circulating Calprotectin as a Predictive and Severity Biomarker in Patients with COVID-19

Background: New tools for the assessment and prediction of the severity of hospitalized COVID-19 patients can help direct limited resources to patients with the greatest need. Circulating levels of calprotectin (S100A8/S100A9) reflect inflammatory activity in multiple conditions, and have been descr...

Descripción completa

Detalles Bibliográficos
Autores principales: Norman, Gary L., Navaz, Sherwin A., Kanthi, Yogendra, Albesa, Roger, Mahler, Michael, Knight, Jason S., Zuo, Yu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Brief Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9221789/
https://www.ncbi.nlm.nih.gov/pubmed/35741134
http://dx.doi.org/10.3390/diagnostics12061324

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9221789/
https://www.ncbi.nlm.nih.gov/pubmed/35741134
http://dx.doi.org/10.3390/diagnostics12061324

Ejemplares similares